Bioporto A/S
OTC:THOXF
Bioporto A/S
OTC:THOXF
Price:
0.149
USD
Market Closed
Market Cap:
$64m
Balance Sheet
Balance Sheet Decomposition
Bioporto A/S
Bioporto A/S
Balance Sheet Decomposition is not available for
Bioporto A/S
Bioporto A/S
Balance Sheet
Bioporto A/S
Bioporto A/S
Currency: DKK
| Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
3
|
9
|
0
|
27
|
13
|
14
|
14
|
14
|
8
|
43
|
25
|
35
|
36
|
47
|
47
|
18
|
108
|
46
|
82
|
66
|
60
|
|
| Cash Equivalents |
3
|
9
|
0
|
27
|
13
|
14
|
14
|
14
|
8
|
43
|
25
|
35
|
36
|
47
|
47
|
18
|
108
|
46
|
82
|
66
|
60
|
|
| Total Receivables |
2
|
2
|
1
|
2
|
2
|
2
|
3
|
3
|
5
|
5
|
6
|
8
|
8
|
12
|
12
|
11
|
13
|
14
|
11
|
10
|
17
|
|
| Accounts Receivables |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
4
|
5
|
6
|
8
|
6
|
7
|
7
|
3
|
2
|
8
|
|
| Other Receivables |
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
4
|
3
|
6
|
4
|
5
|
6
|
7
|
8
|
8
|
9
|
|
| Inventory |
4
|
7
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
3
|
4
|
4
|
3
|
3
|
3
|
4
|
5
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
6
|
2
|
2
|
|
| Total Current Assets |
9
|
19
|
4
|
33
|
18
|
19
|
20
|
21
|
18
|
51
|
36
|
47
|
48
|
63
|
63
|
34
|
125
|
64
|
101
|
82
|
84
|
|
| PP&E Net |
23
|
26
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
5
|
13
|
14
|
5
|
2
|
9
|
|
| PP&E Gross |
23
|
26
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
5
|
13
|
14
|
5
|
2
|
9
|
|
| Accumulated Depreciation |
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
0
|
2
|
2
|
0
|
2
|
5
|
8
|
11
|
11
|
13
|
15
|
|
| Intangible Assets |
20
|
26
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Goodwill |
28
|
28
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
|
| Other Long-Term Assets |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
|
| Other Assets |
28
|
28
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
81
N/A
|
100
+23%
|
5
-95%
|
34
+606%
|
19
-43%
|
20
+6%
|
21
+4%
|
21
+1%
|
18
-14%
|
52
+185%
|
37
-28%
|
49
+32%
|
51
+3%
|
66
+30%
|
66
+1%
|
43
-36%
|
140
+229%
|
81
-42%
|
109
+34%
|
90
-17%
|
96
+7%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
2
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
3
|
1
|
1
|
1
|
1
|
3
|
4
|
3
|
5
|
4
|
10
|
7
|
6
|
|
| Short-Term Debt |
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
4
|
0
|
0
|
0
|
0
|
0
|
13
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
3
|
3
|
3
|
|
| Other Current Liabilities |
1
|
1
|
2
|
2
|
2
|
3
|
4
|
3
|
3
|
8
|
7
|
3
|
4
|
5
|
5
|
9
|
23
|
18
|
17
|
15
|
11
|
|
| Total Current Liabilities |
4
|
3
|
12
|
4
|
4
|
5
|
6
|
5
|
19
|
9
|
8
|
4
|
5
|
9
|
9
|
15
|
31
|
25
|
31
|
25
|
20
|
|
| Long-Term Debt |
3
|
15
|
11
|
0
|
0
|
0
|
12
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
8
|
11
|
7
|
4
|
8
|
|
| Deferred Income Tax |
7
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
14
N/A
|
26
+79%
|
22
-12%
|
4
-80%
|
4
-18%
|
5
+31%
|
18
+267%
|
17
-2%
|
19
+12%
|
9
-54%
|
9
-5%
|
5
-47%
|
6
+41%
|
10
+50%
|
10
+5%
|
17
+74%
|
39
+127%
|
35
-10%
|
38
+9%
|
30
-23%
|
28
-5%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
66
|
73
|
73
|
115
|
115
|
126
|
126
|
135
|
141
|
118
|
118
|
130
|
142
|
156
|
166
|
175
|
267
|
268
|
335
|
380
|
430
|
|
| Retained Earnings |
1
|
1
|
91
|
85
|
99
|
111
|
125
|
134
|
145
|
75
|
89
|
85
|
98
|
99
|
109
|
149
|
167
|
222
|
264
|
320
|
361
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
1
|
0
|
0
|
0
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
|
| Total Equity |
67
N/A
|
74
+11%
|
18
N/A
|
29
N/A
|
16
-47%
|
15
-1%
|
3
-79%
|
4
+19%
|
1
N/A
|
43
N/A
|
29
-33%
|
44
+55%
|
44
0%
|
56
+27%
|
56
+0%
|
25
-55%
|
101
+299%
|
46
-54%
|
70
+53%
|
60
-14%
|
68
+13%
|
|
| Total Liabilities & Equity |
81
N/A
|
100
+23%
|
5
-95%
|
34
+606%
|
19
-43%
|
20
+6%
|
21
+4%
|
21
+1%
|
18
-14%
|
52
+185%
|
37
-28%
|
49
+32%
|
51
+3%
|
66
+30%
|
66
+1%
|
43
-36%
|
140
+229%
|
81
-42%
|
109
+34%
|
90
-17%
|
96
+7%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
29
|
32
|
32
|
51
|
51
|
56
|
56
|
60
|
60
|
118
|
118
|
157
|
43
|
47
|
50
|
53
|
277
|
278
|
348
|
380
|
430
|
|
Switch to:
Switch to:
See Also
Discover More
